“…A very recent review of the literature up to the 30th of May 2014 identified 16 reported cases of AZA-induced SS (table 2) [4,5,6,7,8,10,11,12,13,14,15,16,17]. Analysis of these 16 reported cases shows an age distribution upon onset ranging from 9 to 89 years, an association of AZA-induced SS with IBD in 13 of 16 cases (81%), and an onset within the first month of AZA therapy (with an average time to onset of 33 days, range 7-330) in 15 of 16 patients (94%) (table 2).…”